#USA #Westborough #Olympus #Endocision #cryobiopsy

Olympus and Endocision Announce Global Partnership for Cryobiopsy Technology

Overview
Olympus Corporation has made headlines with its latest partnership with Endocision, a Canadian medical technology firm. This strategic collaboration involves the exclusive global distribution of a groundbreaking flexible cryocatheter system designed for use in respiratory applications. With this agreement, Olympus aims to bolster its existing portfolio of respiratory products while enhancing clinical capabilities in diagnostic and therapeutic procedures.

Expanding Respiratory Solutions
The new flexible cryocatheter is a portable, single-use device tailored for various bronchoscopic procedures. It marks a significant addition to Olympus’s range of respiratory technologies, which already includes advanced tools such as endobronchial ultrasound (EBUS) systems, which are essential for analyzing lung tissues and lymph nodes. According to Seiji Kuramoto, Executive Director of Olympus’s Surgical and Interventional Solutions Division, this partnership represents a commitment to improving respiratory solutions and outcomes for patients.

Innovative Cryobiopsy Capabilities
The cryocatheter system is designed with portability in mind, allowing it to function without the need for electrical power or large carbon dioxide cylinders. This feature significantly expands its accessibility for cryobiopsy procedures across various clinical environments, such as intensive care units, emergency rooms, and bronchoscopic suites. As cryotechnology has become integral in interventional pulmonology, the capability to carry out cryobiopsy offers a transformative means for tissue retrieval and therapeutic interventions within the respiratory tract.

Clinical applications include transbronchial cryobiopsy for tissue sampling, cryo-extraction of foreign bodies, blood clots, and mucus plugs, as well as interventions aimed at tumor reduction and airway recanalization. Research has shown that cryobiopy may yield larger tissue samples while minimizing tissue damage due to compression, which facilitates improved histopathological and molecular analyses compared to traditional forceps biopsy methods.

Endocision’s Commitment to Innovation
Moishe Liberman, President and Medical Director at Endocision, expressed enthusiasm about collaborating with Olympus. He noted that the cryocatheter system supports a wide variety of bronchoscopic applications, enhancing the reach of cryotechnology in clinical settings. This partnership is positioned to drive forward advances in both interventional pulmonology and thoracic endoscopy.

Upcoming Presentation at the AABIP Congress
Olympus and Endocision plan to showcase the innovative cryocatheter system at the annual conference of the American Association for Bronchology and Interventional Pulmonology (AABIP) from August 20 to 22 in Denver, marking a significant milestone in the introduction of this new technology to the medical community.

About Olympus
Olympus is dedicated to creating innovative medical technologies that enhance the quality of life by supporting health professionals in the early detection and treatment of diseases. With over a century of history, the company continues to strive for excellence in medical solutions designed for effective results.

About Endocision
Founded in 2019, Endocision specializes in developing innovative cryogenic devices aimed at diagnosing and treating lung diseases. The company is dedicated to improving clinical outcomes with safer and more effective pulmonary intervention technologies.

For more information on Olympus, visit their website and follow their LinkedIn page. For details about Endocision, check their website as well.